Reserve your spot today
About the webinar
Viruses are known to be highly susceptible to mutations, often resulting in the emergence of variant strains. While some will disappear, others will persist and challenge our global healthcare system, just as we saw with the COVID-19 pandemic.
The pandemic is the most recent example of why rapid development of new detection strategies is more crucial than ever, especially when new variants demonstrate improved transmissibility or virulence. Co-presented by OCMS Bio and Nicoya Lifesciences, this webinar will present current strategies being applied in antibody discovery to accelerate the development of diagnostic tools for emerging viral variants.
Join us in a conversation with Scott Dessain (OCMS) and Marko Jovic (Nicoya), who will discuss the application of novel mAb screening technology and surface plasmon resonance (SPR) for rapid discovery and characterization of variant-specific antibodies, and will delve into the future of immunodiagnostics.
Viruses are known to be highly susceptible to mutations, often resulting in the emergence of variant strains. While some will disappear, others will persist and challenge our global healthcare system, just as we saw with the COVID-19 pandemic.
The pandemic is the most recent example of why rapid development of new detection strategies is more crucial than ever, especially when new variants demonstrate improved transmissibility or virulence. Co-presented by OCMS Bio and Nicoya Lifesciences, this webinar will present current strategies being applied in antibody discovery to accelerate the development of diagnostic tools for emerging viral variants.
Join us in a conversation with Scott Dessain (OCMS) and Marko Jovic (Nicoya), who will discuss the application of novel mAb screening technology and surface plasmon resonance (SPR) for rapid discovery and characterization of variant-specific antibodies, and will delve into the future of immunodiagnostics.
Our speakers
Scott Dessain
Founder and Chief Scientific Officer, OCMS Bio
Insert bio here
Senior Product Manager
Nicoya
Scott Dessain
Founder and Chief Scientific Officer, OCMS Bio
Scott Dessain
Founder and Chief Scientific Officer, OCMS Bio
Insert bio here
Senior Product Manager
Nicoya
Marko Jovic
Training and Development Manager, Nicoya
We look forward to you joining us!
Who should attend
Professors
Industry Scientists
Lab Managers
Core Managers
- Grad Students & Postdocs
- Anyone interested in learning more!
Professors
Graduate Students & Postdocs
Industry Scientists
Laboratory Managers
Core Managers
Detecting emerging viral variants through
rapid antibody discovery and characterization
Detecting emerging viral variants through rapid
antibody discovery
and characterization
Marko Jovic
Training and Development Manager, Nicoya
Insert bio here
Senior Product Manager
Nicoya
Our speakers
What you'll learn
Challenges of emerging viral variants
New strategies for viral detection
Accelerating antibody discovery with rapid screening and characterization
Emerging technologies for mAb engineering
LIVE WEBINAR
LIVE WEBINAR
Insert bio here
Insert bio here
Overcoming the barriers to antibody discovery with on-cell mAb screening
and surface plasmon resonance
Scott Dessain, MD, PhD
Marko Jovic, PhD
Founder, CSO
at OCMS
Training and Development
Manager at Nicoya
Professors
Industry Scientists
Lab Managers
Core Managers
- Grad Students & Postdocs
Who should attend
Professors
Graduate Students & Postdocs
Industry Scientists
Laboratory Managers
Core Managers
Anyone interested in learning more!
May 5th, 2022
4 - 4:45 PM CEST | 10 - 10:45 AM EDT
May 5th, 4 - 4:45 PM CEST
10 - 10:45 AM EDT
Overcoming the barriers to antibody discovery with on-cell mAb screening and surface plasmon resonance